Assessing the current state of medical education on cannabis in Canada: Preliminary findings from Quebec

Elkrief, Laurent; Belliveau, Julien; D’Ignazio, Tara; Simard, Patrice; Jutras‐Aswad, Didier

doi:10.1093/pch/pxaa015

Cited by 8 publications

(9 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Given the most commonly selected reasons for MC use in this survey (cancer or terminal-illness related symptoms and intractable pain) this may ideally take place during training in fields such as family medicine, palliative care, and pain management. This process could be facilitated by the creation of standardized teaching materials as well as the inclusion of cannabis-specific learning objectives in licensing exams and in the curricula of accreditation committees like the Committee on Accreditation of Canadian Medical Schools [ 15 , 19 ]. Our results suggest that increased training, as in Group D, correlates with a stronger feeling of comfort in knowledge of, counselling on, and prescribing MC.…”

Section: Discussionmentioning

confidence: 99%

“…Many HCPs in Canada may not be familiar with CBM due to the lack of coverage of this topic in professional school. Studies assessing medical education in Canada and around the world have found that most trainees have minimal exposure to CBM-related topics in their curricula [15][16][17][18]. With strong media and public interest surrounding CBM, HCPs are likely to be asked more questions about the topic.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Healthcare practitioner perceptions on barriers impacting cannabis prescribing practices

Hachem

Abdallah

Rueda

et al. 2022

BMC Complement Med Ther

View full text Add to dashboard Cite

Background Canadians seeking medical cannabis (MC) may encounter difficulties in finding a healthcare provider (HCP) who authorizes their access to it. Barriers that HCPs face in authorizing MC are unclear. The objectives of this study were to evaluate HCP opinions, knowledge, comfort, and practice in MC prescribing and counseling on recreational cannabis use, and whether the COVID-19 pandemic affected MC prescribing practices. Methods Eligible participants included HCPs (e.g., attending physicians, nurses, pharmacists) in Canada. A questionnaire evaluating their knowledge, comfort, and practice in medical and recreational cannabis was designed based on instruments developed in previous studies. Between April 13th-December 13th 2021, ninety-one healthcare associations were asked to distribute the survey to their members, and an advertisement was placed in the online Canadian Medical Association Journal. Descriptive statistics were used to analyze the results. Results Twenty-four organizations agreed to disseminate the survey and 70 individuals completed it. Of respondents, 71% were attending physicians or medical residents, while the remainder were nurses, pharmacists or other HCPs. Almost none (6%) received training in MC in professional school but 60% did receive other training (e.g., workshops, conferences). Over half (57%) received more questions regarding MC since recreational cannabis was legalized, and 82% reported having patients who use MC. However, 56% felt uncomfortable or ambivalent regarding their knowledge of MC, and 27% were unfamiliar with the requirements for obtaining MC in Canada. The most common symptoms for recommending MC were pain and nausea, whereas the most common conditions for recommending it were cancer and intractable pain. The strongest barrier to authorizing MC was uncertainty in safe and effective dosage and routes of administration. The strongest barrier to recommending or authorizing MC was the lack of research evidence demonstrating its safety and efficacy. During the pandemic, many respondents reported that a greater number of their patients used cannabis to relieve anxiety and depression. Conclusions Our results suggest that HCPs across Canada who responded to our survey are unfamiliar with topics related to MC. The strongest barriers appear to be lack of clinical research, and uncertainty in safe and effective MC administration. Increasing research, training, and knowledge may help HCPs feel more equipped to make informed treatment/prescribing decisions, which may help to improve access to MC.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Healthcare practitioner perceptions on barriers impacting cannabis prescribing practices

Hachem

Abdallah

Rueda

et al. 2022

BMC Complement Med Ther

View full text Add to dashboard Cite

show abstract

“…Canadian youth (aged [15][16][17][18][19][20][21][22][23][24] have one of the highest rates of cannabis use worldwide 1 2 with prevalence rates that are almost double that of adults. Recent data indicate that 44% of youth aged [16][17][18][19], and 51% of youth aged 20-24, report past year cannabis use versus 21% of adults over the age of 25.…”

Section: Introductionmentioning

confidence: 99%

“…18 19 Service providers also have gaps in knowledge about cannabis use in youth and need more education and training. 20 21 A recent survey conducted in the USA where 11 states have legalised recreational cannabis use found variation and gaps in service providers' knowledge and beliefs on cannabis. Many service providers described discomfort discussing cannabis use with clients.…”

Section: Introductionmentioning

confidence: 99%

Cannabis use among youth in Canada: a scoping review protocol

Kourgiantakis¹,

Edwards²,

Lee³

et al. 2023

Preprint

View full text Add to dashboard Cite

Introduction Canadian youth (aged 15–24) have the highest rates of cannabis use globally. There are increasing concerns about the adverse effects of cannabis use on youth physical and mental health. However, there are gaps in our understanding of risks and harms to youth. This scoping review will synthesise the literature related to youth cannabis use in Canada. We will examine the relationship between youth cannabis use and physical and mental health, and the relationship with use of other substances. We will also examine prevention strategies for youth cannabis use in Canada and how the literature addresses social determinants of health. Methods and analysis Using a scoping review framework developed by Arksey and O’Malley, we will conduct our search in five academic databases: MEDLINE, Embase, APA PsycInfo, CINAHL and Web of Science’s Core Collection. We will include articles published between 2000 and 2021, and articles meeting the inclusion criteria will be charted to extract relevant themes and analysed using a qualitative thematic analysis approach. Ethics and dissemination This review will provide relevant information about youth cannabis use and generate recommendations and gaps in the literature. Updated research will inform policies, public education strategies and evidence-based programming. Results will be disseminated through an infographic, peer-reviewed publication and presentation at a mental health and addiction conference. Ethics approval is not required for this scoping review.

show abstract

“…Canadian youth have a wide range of beliefs about recreational cannabis use, and many have misconceptions and lack information about the risks and harms associated with cannabis use 18 19. Service providers also have gaps in knowledge about cannabis use in youth and need more education and training 20 21. A recent survey conducted in the USA where 11 states have legalised recreational cannabis use found variation and gaps in service providers’ knowledge and beliefs on cannabis.…”

Section: Introductionmentioning

confidence: 99%

Cannabis use among youth in Canada: a scoping review protocol

et al. 2022

View full text Add to dashboard Cite

IntroductionCanadian youth (aged 15–24) have the highest rates of cannabis use globally. There are increasing concerns about the adverse effects of cannabis use on youth physical and mental health. However, there are gaps in our understanding of risks and harms to youth. This scoping review will synthesise the literature related to youth cannabis use in Canada. We will examine the relationship between youth cannabis use and physical and mental health, and the relationship with use of other substances. We will also examine prevention strategies for youth cannabis use in Canada and how the literature addresses social determinants of health.Methods and analysisUsing a scoping review framework developed by Arksey and O’Malley, we will conduct our search in five academic databases: MEDLINE, Embase, APA PsycInfo, CINAHL and Web of Science’s Core Collection. We will include articles published between 2000 and 2021, and articles meeting the inclusion criteria will be charted to extract relevant themes and analysed using a qualitative thematic analysis approach.Ethics and disseminationThis review will provide relevant information about youth cannabis use and generate recommendations and gaps in the literature. Updated research will inform policies, public education strategies and evidence-based programming. Results will be disseminated through an infographic, peer-reviewed publication and presentation at a mental health and addiction conference. Ethics approval is not required for this scoping review.

show abstract

Assessing the current state of medical education on cannabis in Canada: Preliminary findings from Quebec

Cited by 8 publications

References 7 publications

Healthcare practitioner perceptions on barriers impacting cannabis prescribing practices

Healthcare practitioner perceptions on barriers impacting cannabis prescribing practices

Cannabis use among youth in Canada: a scoping review protocol

Cannabis use among youth in Canada: a scoping review protocol

Contact Info

Product

Resources

About